
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Masashi Tanaka, Satoshi Saitô, Takayuki Inoue, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 1992-1992
Open Access | Times Cited: 30
Masashi Tanaka, Satoshi Saitô, Takayuki Inoue, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 1992-1992
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Advances in developing therapeutic strategies for Alzheimer's disease
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Thi Kim Oanh Nguyen, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111623-111623
Open Access | Times Cited: 80
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Thi Kim Oanh Nguyen, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111623-111623
Open Access | Times Cited: 80
Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
Linyu Wu, Xiao‐Hui Xian, Guangyu Xu, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 47
Linyu Wu, Xiao‐Hui Xian, Guangyu Xu, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 47
Oxytocin attenuates microglial activation and restores social and non-social memory in APP/PS1 Alzheimer model mice
María Clara Sellés, Juliana T.S. Fortuna, Yasmin P.R. de Faria, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106545-106545
Open Access | Times Cited: 22
María Clara Sellés, Juliana T.S. Fortuna, Yasmin P.R. de Faria, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106545-106545
Open Access | Times Cited: 22
Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment
Mariagiovanna Cozza, Lucia Amadori, Virginia Boccardi
Journal of the Neurological Sciences (2023) Vol. 454, pp. 120866-120866
Open Access | Times Cited: 17
Mariagiovanna Cozza, Lucia Amadori, Virginia Boccardi
Journal of the Neurological Sciences (2023) Vol. 454, pp. 120866-120866
Open Access | Times Cited: 17
AIEgen‐enhanced protein imaging: Probe design and sensing mechanisms
Sanaz Naghibi, Tong Chen, Amin Jamshidi Ghahfarokhi, et al.
Aggregate (2021) Vol. 2, Iss. 3
Closed Access | Times Cited: 39
Sanaz Naghibi, Tong Chen, Amin Jamshidi Ghahfarokhi, et al.
Aggregate (2021) Vol. 2, Iss. 3
Closed Access | Times Cited: 39
Cilostazol for Secondary Stroke Prevention
Adam de Havenon, Kevin N. Sheth, Tracy E. Madsen, et al.
Stroke (2021) Vol. 52, Iss. 10
Open Access | Times Cited: 36
Adam de Havenon, Kevin N. Sheth, Tracy E. Madsen, et al.
Stroke (2021) Vol. 52, Iss. 10
Open Access | Times Cited: 36
The physiological mechanism and effect of resistance exercise on cognitive function in the elderly people
Cheng Aijie, Zhao Zhiwei, Hengxu Liu, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 25
Cheng Aijie, Zhao Zhiwei, Hengxu Liu, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 25
Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis
Nils G. Margraf, Ulf Jensen‐Kondering, Caroline Weiler, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 20
Nils G. Margraf, Ulf Jensen‐Kondering, Caroline Weiler, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 20
Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases
Rahat Ullah, Eun Jeong Lee
Experimental Neurobiology (2023) Vol. 32, Iss. 4, pp. 216-246
Open Access | Times Cited: 12
Rahat Ullah, Eun Jeong Lee
Experimental Neurobiology (2023) Vol. 32, Iss. 4, pp. 216-246
Open Access | Times Cited: 12
Computational Approaches to Evaluate the Acetylcholinesterase Binding Interaction with Taxifolin for the Management of Alzheimer’s Disease
Varish Ahmad, Ibrahim Alotibi, Anwar A. Alghamdi, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 674-674
Open Access | Times Cited: 4
Varish Ahmad, Ibrahim Alotibi, Anwar A. Alghamdi, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 674-674
Open Access | Times Cited: 4
A Case of Cerebral Amyloid Angiopathy With Recurrent Hemorrhagic and Ischemic Strokes Under Direct Oral Anticoagulant Therapy for Atrial Fibrillation
Junichi Uemura, Shinji Yamashita, Yoshiki Yagita, et al.
Cureus (2025)
Open Access
Junichi Uemura, Shinji Yamashita, Yoshiki Yagita, et al.
Cureus (2025)
Open Access
One-Year Radiologic Progression in Sporadic and Hereditary Cerebral Amyloid Angiopathy
Maaike C. van der Plas, Emma A. Koemans, M. Schipper, et al.
Neurology (2025) Vol. 104, Iss. 9
Closed Access
Maaike C. van der Plas, Emma A. Koemans, M. Schipper, et al.
Neurology (2025) Vol. 104, Iss. 9
Closed Access
Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer’s Disease
Teng Wan, Mingyuan Fu, Yan Jiang, et al.
Neurochemical Research (2021) Vol. 47, Iss. 2, pp. 205-217
Open Access | Times Cited: 26
Teng Wan, Mingyuan Fu, Yan Jiang, et al.
Neurochemical Research (2021) Vol. 47, Iss. 2, pp. 205-217
Open Access | Times Cited: 26
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
Satoshi Saitô, Masashi Tanaka, Noriko Satoh‐Asahara, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Satoshi Saitô, Masashi Tanaka, Noriko Satoh‐Asahara, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Azeliragon ameliorates Alzheimer’s disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway
Lijuan Yang, Yepei Liu, Yuanyuan Wang, et al.
Clinics (2021) Vol. 76, pp. e2348-e2348
Open Access | Times Cited: 23
Lijuan Yang, Yepei Liu, Yuanyuan Wang, et al.
Clinics (2021) Vol. 76, pp. e2348-e2348
Open Access | Times Cited: 23
A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism
Kentaro Matsuzaki, Akira Nakajima, Yuanqiang Guo, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1847-1847
Open Access | Times Cited: 16
Kentaro Matsuzaki, Akira Nakajima, Yuanqiang Guo, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1847-1847
Open Access | Times Cited: 16
Case Report: Taxifolin for neurosurgery-associated early-onset cerebral amyloid angiopathy
Maxwell C. Y. Choi, Tiffany H. P. Law, Sirong Chen, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
Maxwell C. Y. Choi, Tiffany H. P. Law, Sirong Chen, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
The role of neuroinflammation in cerebral amyloid angiopathy
Hilde van den Brink, Sabine Voigt, Mariel G. Kozberg, et al.
EBioMedicine (2024) Vol. 110, pp. 105466-105466
Closed Access | Times Cited: 3
Hilde van den Brink, Sabine Voigt, Mariel G. Kozberg, et al.
EBioMedicine (2024) Vol. 110, pp. 105466-105466
Closed Access | Times Cited: 3
FermentedAngelica sinensisactivates Nrf2 signaling and modulates the gut microbiota composition and metabolism to attenuated -gal induced liver aging
Xuerui Lu, Junxiang Li, Yingchun Ma, et al.
Food & Function (2022) Vol. 14, Iss. 1, pp. 215-230
Closed Access | Times Cited: 11
Xuerui Lu, Junxiang Li, Yingchun Ma, et al.
Food & Function (2022) Vol. 14, Iss. 1, pp. 215-230
Closed Access | Times Cited: 11
Amyloid-β: A potential mediator of aging-related vascular pathologies
Fazlullah Khan, Hongyu Qiu
Vascular Pharmacology (2023) Vol. 152, pp. 107213-107213
Open Access | Times Cited: 6
Fazlullah Khan, Hongyu Qiu
Vascular Pharmacology (2023) Vol. 152, pp. 107213-107213
Open Access | Times Cited: 6
The Role of a Pathological Interaction between β-amyloid and Mitochondria in the Occurrence and Development of Alzheimer’s Disease
Н. С. Николаева, Ekaterina Yandulova, Yulia Aleksandrova, et al.
Acta Naturae (2022) Vol. 14, Iss. 3, pp. 19-34
Open Access | Times Cited: 9
Н. С. Николаева, Ekaterina Yandulova, Yulia Aleksandrova, et al.
Acta Naturae (2022) Vol. 14, Iss. 3, pp. 19-34
Open Access | Times Cited: 9
CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex
Carson D. Whinnery, Ying Nie, Danilo S. Boskovic, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Carson D. Whinnery, Ying Nie, Danilo S. Boskovic, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Triggering receptor expressed on myeloid cells 2 activation downregulates toll‐like receptor 4 expression and ameliorates cognitive impairment in the Aβ1‐42‐induced Alzheimer's disease mouse model
Zhangjin Qin, Min Gu, Jian Zhou, et al.
Synapse (2020) Vol. 74, Iss. 10
Closed Access | Times Cited: 11
Zhangjin Qin, Min Gu, Jian Zhou, et al.
Synapse (2020) Vol. 74, Iss. 10
Closed Access | Times Cited: 11
Discovery of Active Ingredients Targeted TREM2 by SPR Biosensor-UPLC/MS Recognition System, and Investigating the Mechanism of Anti-Neuroinflammatory Activity on the Lignin-Amides from Datura metel Seeds
Siyi Wang, Yan Liu, Xiaomao Li, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5946-5946
Open Access | Times Cited: 10
Siyi Wang, Yan Liu, Xiaomao Li, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5946-5946
Open Access | Times Cited: 10
CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex
Carson D. Whinnery, Ying Nie, Danilo S. Boskovic, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 601-601
Open Access | Times Cited: 1
Carson D. Whinnery, Ying Nie, Danilo S. Boskovic, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 601-601
Open Access | Times Cited: 1